Divya Veerapaneni

ORCID: 0000-0002-5082-9752
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroblastoma Research and Treatments
  • Systemic Sclerosis and Related Diseases
  • Chronic Kidney Disease and Diabetes
  • AI in cancer detection
  • Topic Modeling
  • Colorectal Cancer Screening and Detection
  • Cancer, Hypoxia, and Metabolism
  • Social Media in Health Education
  • Lung Cancer Research Studies
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Multimodal Machine Learning Applications
  • Radiomics and Machine Learning in Medical Imaging

The University of Texas Southwestern Medical Center
2024

Cancer Research Center
2024

Boston University
2021-2024

Solid tumors, especially those with aberrant MYCN activation, often harbor an immunosuppressive microenvironment to fuel malignant growth and trigger treatment resistance. Despite this knowledge, there are no effective strategies tackle problem. We found that chemokine-like factor ( CKLF ) is highly expressed by various solid tumor cells transcriptionally up-regulated MYCN. Using the MYCN-driven high-risk neuroblastoma as a model system, we demonstrated early premalignant stage, secrete...

10.1126/sciadv.adh9547 article EN cc-by-nc Science Advances 2024-03-15

Abstract The proliferation of scientific podcasts has generated an extensive repository audio content, rich in specialized terminology, diverse topics, and expert dialogues. Here, we introduce a computational framework designed to enhance large language models (LLMs) by leveraging this informational content from publicly accessible podcast data across science, technology, engineering, mathematics medical (STEMM) disciplines. This dataset, comprising over 3, 700 hours was transcribed generate...

10.1101/2024.07.11.24310304 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-07-12

Abstract Neuroblastoma, especially those with aberrant MYCN activation, often harbor an immunosuppressive microenvironment to fuel malignant growth and trigger treatment resistance. Despite this knowledge, there are no effective strategies tackle problem. Here we combined analyses of human neuroblastoma live tracking functional studies the tumor (TME) in zebrafish. We identified chemokine-like factor (CKLF) as a key driver MYCN-mediated immunosuppression aggression. showed that...

10.1158/1538-7445.tumbody-c002 article EN Cancer Research 2024-11-17

Abstract Interstitial fibrosis and tubular atrophy (IFTA) on a renal biopsy are strong indicators of disease chronicity prognosis. Techniques that typically used for IFTA grading remain manual, leading to variability among pathologists. Accurate estimation using computational techniques can reduce this provide quantitative assessment by capturing the pathologic features. Using trichrome-stained whole slide images (WSIs) processed from human biopsies, we developed deep learning (DL) framework...

10.1101/2021.01.03.21249179 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-01-04

Abstract Neuroblastoma, especially those with aberrant MYCN activation, often harbor an immunosuppressive microenvironment to fuel malignant growth and trigger treatment resistance. Despite this knowledge, there are no effective strategies tackle problem. Here we combined analyses of human neuroblastoma live tracking functional studies the tumor (TME) in zebrafish. We identified a tumor-associated chemokine (TAC) as key driver MYCN-mediated immunosuppression aggression. Taking advantage vivo...

10.1158/1535-7163.targ-23-lb_c20 article EN Molecular Cancer Therapeutics 2023-12-01
Coming Soon ...